RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...
Researchers developed DoriVac, a DNA origami-based vaccine platform that precisely arranges antigens and adjuvants to enhance ...
Overview of Peptide Cancer Vaccine MarketThe Global Peptide Cancer Vaccine Market is valued at USD 1.2 Billion in 2024 and is projected to reach a value of USD 15.72 Billion by 2035 at a CAGR ...
A multi-disciplinary research team at the Wyss Institute at Harvard University, Dana-Farber Cancer Institute, and ...
Wyss Institute's DoriVac combined vaccine and adjuvant technology uses nanoscale precision enabled by DNA origami to induce broad immunity against ...
Morning Overview on MSN
Universal vaccine research advances, but a broad shot is still years away
The U.S. government and academic labs are pushing multiple universal vaccine candidates through early clinical trials, targeting influenza strains and coronaviruses that mutate faster than today’s ...
The global nasal drug delivery technology market is projected to grow at a CAGR of approximately 7% over the next five years.
A futuristic “DNA origami” vaccine platform may one day outperform mRNA shots while being easier to produce and distribute. Credit: Shutterstock Scientists have developed a new DNA origami–based ...
The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever, and general ...
Malaria is caused by a parasite that is spread to humans by infected mosquitoes. In 2024, almost 282 million people worldwide were infected and 610,000 died, according to the World Health Organization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results